• Realm tanks again as second drug fails phase 2 fiercebiotech
    August 15, 2018
    Realm Therapeutics has reported its second midphase flop of the year. The setback threatens to wipe out Realm’s clinical-phase pipeline, leaving the immunology player with just a preclinical acne asset that features the same active ingredient as the faile
PharmaSources Customer Service